Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.

about

Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.

Item

http://www.wikidata.org/entity/Q41542151

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Urokinase-type plasminogen act ...... ognostic value in oral cancer.

@en

type

Item

label

Urokinase-type plasminogen act ...... ognostic value in oral cancer.

@en

prefLabel

Urokinase-type plasminogen act ...... ognostic value in oral cancer.

@en

P1476

Urokinase-type plasminogen act ...... rognostic value in oral cancer

@en

P2093

Birgitte Wittenborg Charabi

http://www.w3.org/2001/XMLSchema#string

David Hebbelstrup Jensen

http://www.w3.org/2001/XMLSchema#string

Giedrius Lelkaitis

http://www.w3.org/2001/XMLSchema#string

Karina Juhl

http://www.w3.org/2001/XMLSchema#string

Katalin Kiss

http://www.w3.org/2001/XMLSchema#string

Morten Persson

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical margins and survival after head and neck cancer surgery.

Updated overview of current biomarkers in head and neck carcinoma

Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography.

Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.

Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC)

Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer

Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.

P2888

s12885-017-3563-3

P304

572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3563-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Kjær

Christian von Buchwald

Jann Mortensen

Julie L Forman

Anders Christensen

Anne Lyngholm Sørensen

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091351323

http://www.w3.org/2001/XMLSchema#string

P698

28841839

http://www.w3.org/2001/XMLSchema#string

P932

5574145

http://www.w3.org/2001/XMLSchema#string